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Oats have been found to be tolerated by most celiac disease patients, and oats are generally considered a good 
and safe addition to the gluten-free diet. There have been claims that some individual oat cultivars are harmful or 
immunogenic for celiac disease patients. In this study, we investigated 26 oat cultivars and landraces from the 
current breeding market and literature. Their total protein content ranged from 15.3% to 23.1% of which avenins 
ranged from 6.8% to 10.9%. Immunological activities of avenins were evaluated using immunochemical analyses 
using monoclonal antibodies (mAb) R5 and G12. No immunological activity of the oat cultivars was observed by 
mAb R5 either in immunoblotting or enzyme-linked immunosorbent assay (ELISA). mAB G12 showed no activity 
in immunoblotting, but gave responses between 13 and 53 mg/kg in ELISA for total avenin extract. To under-
stand the varying G12 activity, avenins were further fractionated. One avenin fraction showed a higher G12 
response than the other fractions. Protein sequence comparison suggests that there is no direct binding to avenin- 
specific T-cell epitopes but the differences in repetitive regions in avenins may contribute to varying results in 
G12 ELISA.   
1. Introduction 
Celiac disease (CD) is an autoimmune disorder with histologic and 
clinical symptoms affects 1.4% of the world population. The onset of CD 
requires both a genetic disposition and environmental factors, including 
the consumption of dietary gluten (Singh et al., 2018). The only 
accepted treatment is a gluten-free diet (GFD) avoiding gluten proteins 
from wheat, barley and rye. CD patients generally include uncontami-
nated or “pure” oats in their GFD for variation, good taste and increased 
satiety (Thies et al., 2014). Oats add beneficial dietary fibre to the GFD, 
and consuming oats has even been reported to improve CD patients’ 
quality of life (Aaltonen et al., 2017; Størsrud et al., 2003a). 
The first long term clinical study was done in Finland in the 90s 
(Janatuinen et al., 2002) and consuming 50–70 g/d of regular com-
mercial oats (a mixture of cultivars) for 5 years was found to be safe for 
adult CD patients. A safe daily dose of oats can be as high as 100 g/d 
(Kemppainen et al., 2008; Størsrud et al., 2003b), and a more recent 
cross-sectional study showed that even longer periods consuming oats 
were safe (Aaltonen et al., 2017). However, the debate on the safety of 
oats remains in the past two decades, where pure oats have been found 
to have some effects in certain individuals (Arentz-Hansen et al., 2004; 
Lundin et al., 2003; Silano et al., 2007). Therefore, it has been under 
investigation whether all oat cultivars are equally safe for CD patients 
(Comino et al., 2011; Gimenez et al., 2017; Real et al., 2012; Silano 
et al., 2007). 
Gluten proteins generally refer to prolamins in wheat (gliadins and 
glutenins), barley (hordeins) and rye (secalins) (Sollid et al., 2012). For 
wheat, barley and rye, prolamins are the main storage proteins, 
constituting 60–80% of the grain’s total protein, whereas oat prolamins 
(avenins) count for around 10% (Shewry, 1999; Wieser et al., 2014). 
According to CODEX STAN 118–1979, foods can be called gluten-free 
when measured gluten levels are under 20 mg/kg. The standard also 
states that although most gluten intolerant people tolerate oats, the 
acceptance of uncontaminated oats in GF foods can be decided at a 
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national level. According to the legislation of EU, oats and oat products 
can be considered gluten-free as long as there is no cross-contamination 
with other gluten containing cereals and the gluten content of the food is 
under 20 mg/kg ((EU) No 828/2014). The recommended method for 
gluten determination is the enzyme-linked immunoassay (ELISA) Men-
dez method using a monoclonal antibody (mAb) called R5, which was 
raised against rye secalins. R5 recognises mainly sequences QQPFP, 
QQQFP, LQPFP and QLPFP, and can detect prolamins of wheat, barley 
and rye, but does not cross-react with oats (Kahlenberg et al., 2006). 
In addition to mAb R5, some studies have used mAb G12 based 
immunochemical methods to quantify gluten. G12 antibody was raised 
against a model celiac immunogenic peptide derived from wheat alpha- 
gliadin, 33-mer, which contains several T-cell activating epitopes (Shan 
et al., 2002). According to Moron et al. (2008), the main sequences that 
mAb G12 recognized in the 33-mer peptide were QPQLPY and QPQLPF. 
G12 ELISA responses to oats have been previously linked to potential 
T-cell stimulation, and based on this proportional reactivity, used to 
differentiate oat cultivars containing potential celiac immunogenic 
epitopes (Comino et al., 2011). Two avenin-specific T-cell epitopes have 
been reported: DQ2.5-ave-1a PYPEQEEPF and DQ2.5-ave-1b PYPE-
QEQPF (bolded E is the deamidation site, where Q→E) (Sollid et al., 
2012). However, there has been no evidence that G12 directly binds to 
avenin-specific T-cell epitopes. Some studies have investigated the 
different immunogenic profiles of oat cultivars (Gimenez et al., 2017; 
Londono et al., 2013; Mujico et al., 2011), but the relation of immu-
nochemical analysis and T-cell activation studies is still not clear and has 
yet to be verified clinically. Additionally, based on genomic data, 
avenin-specific T-cell epitopes have been found to naturally exist in all 
oat cultivars, but as there are no known mAb G12 and R5 recognition 
sites in oats, the varying G12 and R5 responses should not be used as an 
indicator of oat celiac immunogenicity (Londono et al., 2013). It is 
critical to have further clarity on the issue for the development and 
creditable validation of gluten detection methods and for evaluating the 
celiac immunogenicity of avenins in oats. 
The aim of this research was to evaluate the immunochemical 
sensitivity of avenins from 26 cultivars and landraces to two most used 
monoclonal antibodies R5 and G12. Additionally, we wanted to assess 
whether avenins differ in sensitivity to the chosen antibodies between 
the oat cultivars and landraces in our collection as well as between 
avenin groups within individual oat cultivars. The oat cultivars and 
landraces in this study were chosen based on earlier literature (i.a. 
Gimenez et al., 2017; Kemppainen et al., 2008; Mujico et al., 2011) and 
relevance to current Finnish gluten-free agriculture. 
2. Materials and methods 
2.1. Materials 
Chemicals and solvents. Acetonitrile (ACN, gradient grade  99.9%) 
and trifluoroacetic acid (TFA, HPLC grade  99.0%) were acquired from 
Sigma Aldrich (St. Louis, MO, USA). Ethanol (ETAX Aa,  99.5%) was 
acquired from Altia Plc (Rajamaki, Finland) and desiccated bovine 
serum albumin (BSA) from Santa Cruz Biotechnology, Inc. (Dallas, TX, 
USA). 
Oat flours. 26 oat (Avena sativa) cultivars and landraces (marked with 
*) were used in this study: Aslak (FI), Astor (NL), Avanti (NO), Avetron 
(NO), Belinda (SE), Clav 1015 (US), Clav 1016* (US), Donna (FI), Helja* 
(FI), Mansholt III (NL), Matilda (SE), Matty (GE), Mirella (FI), Peppi (FI), 
Perttu (FI), PI 219763* (GR), PI 287264* (GR), PI 287265* (GR), PI 
287266* (GR), PI 564724 (IT), La Prevision (AR), Riina (FI), Salo (SE), 
Ouderwetse (NL), Troshaver uit Besel (NL), and Wodan (NL). Oat cul-
tivars and landraces were obtained from the Natural Resources Institute 
Finland (Luke), Jokioinen, Finland, where the cultivars were grown in 
controlled growth chambers. Oat seeds were carefully dehulled by hand 
and milled to flour with a coffee mill dedicated to pure oats to avoid 
cross-contamination with other cereals. 
2.2. Protein content and avenin extraction 
Protein content of oat flours was determined using the Dumas method 
(LECO CN828, LECO Corporation, MI, USA). Crude protein content was 
calculated by multiplying nitrogen content by factor 5.4 used for oat 
protein content (Salo-Vaananen and Koivistoinen, 1996). 
Avenin extraction and fractionation. The aqueous ethanol soluble 
fraction oat avenins in 0.1 g oat flour, or 0.03 g crushed oat groats for 
single seed analyses, were extracted by adding 0.5 ml 60% ethanol (v/v) 
and incubating for 30 min at 50 C with constant agitation at 300 rpm. A 
clear supernatant was collected after centrifugation 23,000 x g for 10 
min and stored for analysis in separate tubes in dark in ambient tem-
perature. To obtain complete extraction of extractable avenins, the 
sample pellet was extracted with 0.5 ml 60% ethanol (v/v) up to four 
times and combined. For avenin quantification, the same pellet was 
extracted with 0.5 ml 60% ethanol (v/v) three times and combined. The 
proteins in the extract were separated on a C8 column (condition as in 
2.4) and the avenin protein content was calculated based on the peak 
area of avenins using bovine serum albumin as standard in the linear 
range of 0–100 μg. The avenin recovery was counted from the total 
protein content and total flour. 
2.3. Electrophoretic separation of avenins 
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS- 
PAGE, Invitrogen NuPage 12% Bis-Tris, 1.0 mm, Thermofisher Life 
Technologies) was used to analyse avenin compositions of selected oat 
cultivars. The SDS-PAGE sample buffer contained 29% 0.5 M Tris-HCl 
(pH 6.8) (v/v), 23.5% glycerol (v/v), 4.7% SDS (m/v), 5% 2-mercaptoe-
thanol (v/v) and trace amount of bromophenol blue. Each avenin extract 
was mixed with sample buffer in ratio 2:3 (v/v) and boiled for 3 min. 
Samples and pre-stained protein standard (Novex Sharp LC5800, range 
3.5–260 kDa) were loaded to gel wells. Invitrogen Bolt MOPS was used 
as the SDS running buffer, the applied voltage was 200 V and the 
running time was 55 min. Coomassie Brilliant blue R-250 was used for 
staining. Imaging was carried out using a Canon EOS 400D camera 
against a light table. 
2.4. Identification and quantification of avenins 
Chromatographic analyses were performed using an Agilent 1100 
reversed-phase high-performance liquid chromatograph (RP-HPLC) 
system with a diode array detector. Avenin extract was filtrated (Acro-
disc Syringe filter 13 mm, Minispike with 0.45 μm GHP membrane, Pall 
Corporation) and separated on a Supelco Analytical Discovery BIO wide 
Pore C8-5 column (25 cm  4.6 mm, 5 μm, Bellefonte, PA, USA). 
Chromatographic solvent A was 0.1% trifluoroacetic acid (TFA) (v/v) in 
milliQ-water and B was 0.1% TFA (v/v) in acetonitrile (ACN). An 
acetonitrile gradient was established: 0–2 min: 20% B, 2–3 min: 30% B, 
3–8 min 30% B, 8–58 min 50%. At the end there was a washout step 
making the total run time 75 min. The injection volume for samples was 
50 μl and avenin separation was performed at 50 C at a flow rate of 1 
ml/min. 
2.5. Immunological assays 
Enzyme-linked immunosorbent assay (ELISA) R5 and G12. Two 
sandwich-type ELISA analyses were used to examine whether avenins 
are detected using the method, one with monoclonal antibody (mAb) R5 
(R7001, R-Biopharm, Darmstadt, Germany) and one with mAb G12 
(COKAL0200, Romer Labs, Runcorn, UK). The starting amount of oat 
flour for R5 ELISA was 1.0 g and for G12 ELISA 0.25 g. The flour was 
mixed with 10 ml patented “cocktail solution” or 2.5 ml extraction 
buffer, respectively, and incubated in an air incubator with constant 
agitation for 40 min at 50 C. After cooling, 80% ethanol (v/v) was 
added to the sample at a 1:4 ratio, followed by a 1 h shaking by a rotator 
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at ambient temperature. The samples were centrifuged at 2500 x g for 
10 min, and the supernatant diluted 1:12.5 with dilution buffer before 
performing the assay. Assay procedures on avenin extracts were carried 
out according to kits’ instructions. Washing of microplates was per-
formed using an Asys Atlantis microplate washer (Biochrom Ltd., 
Cambridge, UK). 
Immunoblotting. Immunoblots against mAb R5 and G12 were used to 
detect specific proteins in 26 oat cultivars. The proteins were extracted 
using two methods. In the first, 100 mg oat flour was directly extracted 
by 0.5 ml 60% ethanol (v/v) for 15 min in 50 C water bath with son-
ication. In the second, followed the extraction procedure in ELISA test, 
where 0.25 g oat flour was extracted by 2.5 ml “cocktail solution” at 50 
C for 40 min, followed by adding 7.5 ml 80% ethanol (v/v) after cooling 
and shaking up-side down for 60 min at ambient temperature. Wheat 
(cv. Chinese spring), barley (cv. Barke) and rye (cv. Lo7) flours served as 
positive controls in immunoblots: 50 mg of flour was extracted by 0.5 ml 
60% ethanol (v/v) with 5% 2-mercaptoethanol (v/v) at 50 C for 15 min. 
The protein concentration of the extracts was determined by RC DC 
Protein assay kit (Bio-Rad, Hercules, CA, USA) with a BSA standard. 
After dilution with the same extraction buffers, the protein samples for 
gel electrophoresis was prepared adding lithium dodecyl sulfate sample 
buffer (NuPAGE, NP0007) and 100 mM DTT. An aliquot of 5 μg protein 
of each sample was loaded into a 4–12% Bis-Tris Midi gel (Invitrogen 
NuPAGE, 26 wells, Thermofisher Scientific). The electrophoresis con-
dition was 200 V for 40 min in the presence of MES running buffer. For 
gel electrophoresis unstained Mark 12 (Invitrogen, Thermofisher) was 
served as protein standard, for immunoblots pre-stained SeeBlue Plus2 
(Invitrogen, Thermofisher) was served as protein standard. After elec-
trophoresis, one reference gel was first fixed by 10% TCA for 60 min and 
then stained by Coomassie G-250 with SimplyBlue SafeStain (Invi-
trogen, Thermofisher) overnight and imaged on a Thyphoon Tri Scanner 
(GE Healthcare, Buckinghamshire, UK). For the actual immunoblotting, 
the proteins were transferred to a nitrocellulose transfer membrane 0.45 
μm (Bio-Rad) in the presence of a transfer buffer (25 mM Tris-HCl pH 8.3 
containing 192 mM glycine, 20% methanol (v/v)) by a semidry blotting 
system (Bio-Rad) at 20 V for 60 min. The membranes were blocked by a 
blocking buffer containing phosphate-buffer saline, 0.05% (v/v) Tween 
20 and 5% (w/v) skim milk powder. After an efficient washing step, the 
membranes were incubated with primary antibodies mAb R5 and mAb 
G12 diluted 1:1000 in blocking buffer for 60 min at ambient tempera-
ture; then with secondary goat anti-mouse IgG labelled with alkaline 
phosphatase conjugate diluted 1:5000 in blocking buffer for another 60 
min. The membranes were developed using nitro-blue tetrazolium and 
5-bromo-4-chloro-30-indolyphosphate (1-Step NBT/BCIP substrate so-
lution, Thermo Scientific). To finish, the membranes were washed 
briefly with water and imaged by a CCD camera (Fujifilm LAS-1000, 
Fuji, Japan). 
2.6. Fractionation by RP-HPLC and analysis of avenin immunochemistry 
by SDS-PAGE and G12 ELISA 
Fractionation. Avenin extracts of four cultivars (Matilda, Salo, 
Ouderwetse and Wodan) with high G12 ELISA responses (>40 mg/kg) 
were chosen for fractionation. One-time aqueous ethanol extracted 
avenins were analysed with RP-HPLC (injected 100 μl) and the eluent 
was collected as fractions according to peak retention times (RT). Peaks 
in chromatogram profiles were divided in four groups (A-D) with similar 
RTs across cultivars. The approximate RTs of these groups were A: 
36–38 min, B: 38–41 min, C: 42–44 min and D: 44–49 min. Separate 
peaks within one fraction group were collected separately and distin-
guish with consecutive numbers, e.g. A1 and A2. 
Sample preparation and ELISA. Fractions were concentrated by first 
evaporating acetonitrile under continuous N2 flow at 30 C and then 
water by a vacuum concentrator (Savant SpeedVac Plus SC110A, Pierce 
Reacti Vap III, Thermo Scientific) with a heater (Pierce Reacti-Therm III, 
Thermo Scientific) and a condensation trap (Savant RT100, refrigerated, 
Savant) until dry. Proteins were re-dissolved in 60% ethanol (v/v) for 
SDS-PAGE and “cocktail solution” for G12 ELISA. For SDS-PAGE and 
G12 ELISA, the fractions were treated as extracts and were subjected to 
the same sample treatment as described in section 2.3 and 2.5, respec-
tively. Avenin concentrations were calculated prior to applying them to 
SDS-PAGE or G12 ELISA based on RP-HPLC peak areas at fraction 
collection. A gluten-negative sample (gluten-free tapioca starch, Farina, 
Table 1 
Protein characterisation of 26 oat cultivars and landraces. Total protein content 
calculated using Nx5.4. Avenin content calculated from RP-HPLC. Immuno-
chemical content based on commercial R5 and G12 ELISA kits.  
Cultivar Total protein 
contenta 
Avenin contentb R5 
ELISAc 
G12 
ELISAd 
% of flour % of 
flour 
% of 
proteins 
mg/kg mg/kg 
Aslak 19.3  0.3 1.5 
0.7 
7.8  0.7 <5 30  10 
Astor 18.6  0.2 1.7 
0.2 
9.1  0.2 <5 30  12 
Avanti 16.9  0.1 1.4 
0.5 
8.5  0.5 <5 30  13 
Avetron 18.3  0.07 1.5 
0.02 
8.4  0.03 <5 21  3 
Belinda 15.9  0.03 1.6 
0.1 
9.9  0.1 <5 30  6 
CIav 1015 21.3  0.2 1.8 
0.2 
8.4  0.2 <5 20  6 
CIav 1016* 18.4  0.1 1.7 
0.1 
9.1  0.2 <5 22  7 
Donna 17.1  0.08 1.6 
0.3 
9.5  0.4 <5 17  1 
Helja* 20.4  0.1 1.9 
0.2 
9.3  0.2 <5 17  1 
Mansholt III 19.7  0.05 2.2 
0.1 
10.9 
0.06 
<5 17  2 
Matilda 19.7  0.09 1.9 
0.1 
9.8  0.06 <5 42  9 
Matty 17.7  0.1 1.4 
0.03 
8.1  0.03 <5 25  4 
Mirella 15.3  0.05 1.1 
0.2 
7.5  0.2 <5 34  8 
Peppi 17.4  0.04 1.5 
0.1 
8.4  0.2 <5 22  4 
Perttu 18.2  0.1 1.4 
0.02 
7.6 
0.003 
<5 21  5 
PI 219763* 19.9  0.05 1.7 
0.2 
8.5  0.2 <5 13  3 
PI 287264* 23.1  0.08 2.2 
0.2 
9.4  0.2 <5 24  8 
PI 287265* 20.8  0.1 2.1 
0.3 
10.0  0.3 <5 27  8 
PI 287266* 21.7  0.3 2.0 
0.4 
9.1  0.4 <5 26  8 
PI 564724 20.7  0.4 2.2 
0.2 
10.7  0.2 <5 19  1 
La Prevision 21.4  0.3 2.2 
0.3 
10.2  0.3 <5 26  4 
Riina 21.0  0.09 1.4 
0.2 
6.8  0.2 <5 44  4 
Salo 17.8  0.2 1.4 
0.1 
8.0  0.1 <5 40  11 
Ouderwetse 18.9  0.07 1.7 
0.01 
9.1  0.01 <5 40  12 
Troshaver uit 
Besel 
19.7  0.1 1.7 
0.2 
8.3  0.2 <5 50  11 
Wodan 19.4  0.3 1.8 
0.2 
9.1  0.2 <5 53  6 
*Landrace,  standard error of means. 
a Mean of 3 technical repeats. 
b mean of 2 biological repeats, 2 technical repeats each. 
c 2 technical repeats. 
d mean of 3 biological repeats, 2 technical repeats each. 
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Vuohelan Herkku, FI) was extracted according to kit’s protocol and 
analysed together with other samples in each ELISA run. 
2.7. Identification of fraction proteins by LC-MS/MS 
For the variant responses of avenins fractions, proteins from A2 and 
B from oat cultivar Ouderwetse were identified by LC-MS/MS. Fractions 
were concentrated and digested by trypsin (sequencing grade, Promega, 
Madison, WI,USA) in 0.5 M ammonium bicarbonate using a modified 
filter-aided sample preparation (FASP) method (Scifo et al., 2015). The 
peptides were separated by Easy-nLC system (Thermo Scientific) 
equipped with a reverse phase trapping column Acclaim PepMapTM 100 
(C18, 75 μm  20 mm, 3 μm particles, 100 Å; Thermo Scientific), fol-
lowed by an analytical Acclaim PepMapTM 100 RSLC reversed-phase 
column (C18, 75 μm  250 mm, 2 μm particles, 100 Å; Thermo 
Scientific). The injected sample analytes were trapped at a flow rate of 2 
μl/min in 100% of solution A (0.1% formic acid). After trapping, the 
peptides were separated with a linear gradient with solution B (0.1% 
formic acid/80% acetonitrile) of 120 min: 0–96 min: 3–30% B, 96–103 
min: 30%–40% B,103–107 min: 40%–95% B. Each sample run was 
followed by two empty runs to reduce the sample carryover from pre-
vious runs. Full MS were acquired from 350 to 1400 m/z and the 10 most 
abundant precursor ions were selected for fragmentation with 30 s dy-
namic exclusion time. Ions with 2, 3, and 4 charge were selected for 
MS/MS analysis. 
The raw files were qualitatively analysed by Proteome Discoverer 
(PD), version 2.4.0.305 (Thermo Scientific, USA). The identification of 
proteins by PD was performed against NCBI/Other green plants protein 
database (release June-2020 with Viridiplantae green plants (8,834,082 
entries) using the built in Mascot engine (Matrix Science, UK)). Protein 
Fig. 1. (a) SDS-PAGE of avenin extracts; (b) Immu-
noblot of avenin extracts against mAb R5; (c) 
Immunoblot of avenin extracts against mAb G12. 
Lanes 1 and 9: protein standards. Protein standards 
were (a) Mark 12 and (b), (c) Prestained SeeBlue Plus 
2. Lanes 2–7: 60% ethanol (v/v) extracts from oat 
flours, cultivars 2) Aslak, 3) Avanti, 4) Clav 1015, 5) 
Clav 1016, 6) Donna, and 7) Mirella. Lane 8 and 25, 
barley flour extracted with 60% ethanol (v/v) and 5% 
2-mercaptoethanol (v/v). Lanes 10–24: 2-step 
extraction with extraction buffer and ethanol of oat 
flours, cultivars 10) Aslak, 11) Avanti, 12) Avetron, 
13) Clav 1015, 14) Donna, 15) Helja, 16) Matilda, 17) 
Matty, 18) Mirella, 19) Perttu, 20) PI287265, 21) 
PI287266, 22) PI564724, 23) Prevision, and 24) 
Riina.   
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identification with the best Mascot scores were chosen. The tolerance 
values for MS and MS/MS were 10 ppm and 0.02 Da, respectively. Two 
missed cleavages were allowed. The oxidation of methionine and dea-
midation of asparagine and glutamine were set as a variable modifica-
tion. The false discovery rate was set to less than 0.01 and a minimum 
length of six amino acids. 
3. Results and discussion 
3.1. Protein characterisation of oat cultivars 
Protein contents of oats ranged from 15.3  0.05% (Mirella) to 23.1 
 0.08% (PI 287264) of which avenins ranged between 6.8  0.2% 
(Riina) and 10.9  0.06% (Mansholt III) (Table 1). One time extraction 
of avenins with 60% aqueous ethanol yielded 84%, two times extraction 
97% and three times extraction 100% of extractable avenins that were 
detectable with the RP-HPLC system. Proteins separated by SDS-PAGE 
can be divided into three different size groups: 30–40 kDa, 20–30 kDa 
and 10–15 kDa (Fig. S1). According to Shewry (1999), the 30–40 kDa 
group was the minor group of avenins and 20–30 kDa group was the 
major group of avenins. The 10–15 kDa group was non-prolamin pro-
teins co-extracted with aqueous ethanol solution and they were not 
recognized in an immunoblot assay with a rabbit polyclonal anti-gliadin, 
as were the 20–30 kDa and 30–40 kDa avenins (data not shown). Elec-
trophoretic separation of avenins reveals band patterns that can be used 
to roughly group the oat cultivars and landraces with resembling band 
patterns. Most of the collection had the two minor bands at 30 kDa with 
slight size variation. Cultivars Avetron, Matty, and Mirella showed only 
one minor band and Greek landraces PI 219763 and PI 287266 had no 
minor bands. 
3.2. Immunological analysis of total avenins 
Followed by the two-step extraction method from the kit manufac-
tures, the prolamin contents from 26 oat cultivars were all less than the 
limit of detection of the R5 sandwich ELISA, meaning less than 1 mg/kg 
and in G12 sandwich ELISA the concentrations ranged from 13  3 mg/ 
kg to 56  6 mg/kg (Table 1). The mAb R5 antibody recognized α-gli-
adins, γ-gliadins and ω1,2-gliadins from wheat, C-hordein, B-hordeins 
and γ-hordeins from barley, γ-40k secalins, γ-75k secalins, ω-secalins 
and HMW-secalins from rye (Fig. S3b). The mAb R5 has high affinity 
towards ω-type prolamins because the recognition epitope QQPFP fre-
quencies is 18 in ω1,2-gliadins (Uniprot accession D2KKB1), 14 in 
ω-secalins (C4NFN9), and 17 in C-hordein (Q41210). However, oat 
avenins do not contain any QQPFP epitopes and the mAb R5 did not 
show cross-reactivity to avenins in the ELISA assay, confirming the oat 
samples were not cross-contaminated by wheat, barley or rye. G12 
antibody recognized α-gliadins, γ-gliadins and ω1,2-gliadins and LMW- 
glutenins from wheat, C-hordein and γ-hordeins from barley, γ-40k 
secalins, γ-75k secalins, and ω-secalins from rye (Fig. S3c). The main 
G12 recognition epitope QPQLPY/QPQLPF was only found once in ω1,2- 
gliadins (Uniprot accession D2KKB1), once in ω-secalins (C4NFN9), 
once in γ-gliadins (P21292), once in α-gliadins (P042721) and three 
times in α-gliadins (P18573) (Lexhaller et al., 2017), indicating G12 
antibody recognises sequences homologues of the 33-mer. However, no 
mAb G12 recognition epitopes were found in oat avenins. In a 
competitive ELISA assay, mAb G12 reacted with oat avenins (IC50 
233 μg/ml), but to a much lesser extent than wheat, barley and rye 
(IC50  1.5–3.8 μg/ml) (Moron et al., 2008). 
To understand the protein recognition of avenins in G12 ELISA, two 
prolamin extraction methods, extraction buffer and aqueous ethanol, 
were compared by immunoblotting. The ELISA kit’s extraction buffer 
contains reducing and chaotropic agents such as 2-mercaptoethanol and 
guanidine hydrochloride, which liberate more proteins from the oats 
than using simply aqueous ethanol (Fig. 1a vs. Fig. S2a). G12 antibodies 
did not recognize the extracted proteins from either of the extraction 
methods in immunoblotting. Some of the cultivars in our collection and 
in Gimenez et al. (2017) were the same. In Gimenez et al. (2017), a 
competitive G12 assay was used instead of a sandwich assay, and their 
G12 results differed slightly from our results (Table 1), e.g. Clav 1015 
(<3 mg/kg), PI219763 (>40 mg/kg), PI287265 (10–20 mg/kg), 
PI564724 (<3 mg/kg) and La Prevision (<3 mg/kg). The oat cultivar 
collection in this study and in Gimenez et al. (2017) showed similarities 
with the three cultivars reported in Comino et al. (2011), which gave no 
R5 ELISA responses, no G12 immunoblot recognition and no T-cell 
stimulating activity. However, Comino et al. (2011) also reported there 
was an oat accession, OM719, which showed high T-cell stimulating 
activity, gave high R5 ELISA responses and high G12 ELISA responses 
that were equivalent to 1.34 μg 33-mer peptide/mg prolamin. This 
amount was in the magnitude of the amount of 33-mer peptides in wheat 
samples, where the amount varied from 4.1 to 23.2 μg/mg α-gliadin by 
LC-MS/MS in wheat samples (Schalk et al., 2017). According to the 
present study’s R5 ELISA and G12 immunoblot results on total avenins, 
our oat cultivar and landrace collection, which included oat cultivars in 
the current market and future breeding programs in Finland, did not 
contain such cultivars with high immunochemical responses similar to 
Fig. 2. (a)–(d): chromatograms of oat avenins extracted by 60% (v/v) ethanol and separated by a C8 column. (a) cv. Matilda; (b) cv. Salo; (c) cv. Ouderwetse; (d) cv. 
Wodan. Letters A-D mark proteins with similar retention times between cultivars. 
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the T-cell stimulating OM719 (Comino et al., 2011). 
3.3. Immunological detection of avenin fractions and protein 
identification 
To investigate the origin of G12 ELISA activity, four oat cultivars 
(Matilda, Salo, Ouderwetse, Wodan) that had > 40 mg/kg in G12 ELISA 
were chosen for fractionation. Fractions were grouped as A to D based on 
peak retention times in RP-HPLC (Fig. 2). The protein profiles of 
collected avenin fractions (A-D) were examined by SDS-PAGE (Fig. 3) 
and each fraction group was found to be of similar molecular weight. 
mAb G12 had the highest affinity towards A2-fraction in the fraction-
ated cultivars, and lowest affinity to D-fractions (Table 2). Among these 
fractions, fractions B-D gave ppm-values less than the actual loaded 
avenin content, while e.g. cv. Ouderwetse A2-fraction gave a response 
over 200 mg/kg. 
Proteins in fractions cv. Ouderwetse A2 and B were then identified. 
Fraction A2 mainly consists of avenin (L0L6J0, 32.8 kDa, Mascot score 
429) identified by three tryptic peptides QAICQVTR, QLAQIPEQLR and 
QFLVQQCSPVAAVPFLR (highlighted green in Fig. 4). Fraction B pro-
teins were identified by two tryptic peptides QFLVQQCSPVAVVPFLR 
and QLAQIPEQLR, which belong to Group C avenin proteins and could 
possibly be identified as Q09114 (Avenin-E, 21.0 kDa, Mascot score 
272), L0L4I8 (29.1 kDa), L0L5G8 (25.7 kDa), L0L841 (22.9 kDa), 
L0L5H5 (24.5 kDa), L0L6K5 (23.1 kDa), L0L8B6 (22.9 kDa), or F4MJY1 
(25.6 kDa). Group C avenins were classified by their two repetitive 
motifs, the first repetitive region contained repeats of PFVQ and second 
region contained repeats of VFQPQLQLQ (Real et al., 2012; Shewry, 
1999). Sequence alignment (Fig. 4) showed that both identified proteins 
in fractions A2 and B had one copy of the avenin-specific T-cell epitope 
(DQ2.5-ave-1) (highlighted yellow in Fig. 4). A sandwich assay would 
need a minimum of two of these epitopes to show any activity against 
the avenin-specific T-cell epitope, yet there were varying G12 ELISA 
responses between the fractions (Table 2). The only differences between 
these sequences were the number of repeats in the repetitive region: 7 
Fig. 3. SDS-PAGE of oat cultivars (a) Matilda, (b) Salo, (c) Ouderwetse, and (d) Wodan. Oat proteins were extracted with 60% ethanol (v/v) and fractionated (A–D) 
using a RP-HPLC method. Invitrogen Novex Sharp was used as a pre-stained protein standard. 
Table 2 
Four oat cultivars (Matilda, Salo, Ouderwetse and Wodan) were fractionated 
(RP-HPLC), dried, re-dissolved in extraction buffer and applied to G12 ELISA. 
Estimation of fraction protein contents were acquired based on RP-HPLC peak 
areas and known amount of re-dissolving buffer. CV% for G12 ELISA was < 11%.  
Cultivar Fraction Estimated protein content G12 ELISAa 
mg/kg mg/kg 
Matilda A1 46.3  0.2 10.1 
A2 46.0  0.2 65.6 
B 43.0  0.01 <5.0 
C 39.0  0.3 6.2 
D1 41.3  0.1 16.6 
D2 25.3  0.3 6.9 
D3 19.4  0.3 5.0 
Salo A 63.6  0.6 36 
B 33.7  0.3 25.7 
C 18.0  0.4 8.8 
D1 28.6  0.9 11.3 
D2 25.1  0.3 7.1 
D3 13.1  0.2 3.9 
Ouderwetse A1 27.7  0.4 11.0 
A2 52.1  0.3 >200 
B 39.0  0.3 8.3 
C 32.9  0.7 4.9 
D1 40.0  0.9 16.3 
D2 17.8  0.2 7.9 
D3 20.3  0.3 6.2 
Wodan A1 18.0  0.3 12.5 
A2 56.5  0.2 42.0 
B 58.3  0.5 6.0 
C 22.1  0.2 5.1 
D1 29.0  0.1 <5.0 
D2 25.5  0.1 11.4 
D3 26.8  0.1 <5.0 
 standard error of means. 
a 3 biological repeats, extracts pooled, 2 technical repeats. 
H.G. Ahola et al.                                                                                                                                                                                                                                
Journal of Cereal Science 95 (2020) 103053
7
repeats of PFVQ in L0L6J vs. 3 repeats in Q09114; 6 repeats of 
VFQPQPQLQ in L0L6J vs. 1 repeat in Q09114 (Fig. 4). G12 binding is 
unlikely to be directly linked to avenin-specific epitopes, but rather to 
the repetitive regions. High number of epitope repeats usually enhances 
antibody binding (Gravekamp et al., 1996), and in this sandwich G12 
ELISA, we suggest the antibody binding was due to these two avenin 
repetitive regions, explaining the variation between the responses of the 
avenin fractions. 
The motif PFVQ was first studied in in vitro T-cell activation tests due 
to its homology with wheat gliadin. An avenin peptide 
QQPFVQQQQQPFVQ, containing this PFVQ motif, did not induce any 
responses from patients’ T-cells, and an avenin peptide 
QQPFVQQQQPFVQQ induced 1/8 patients’ T-cells (Vader et al., 2003). 
Controversially in another study, the same avenin peptide 
QQPFVQQQQQPFVQ stimulated T-cells and induced the release of 
IFN-γ, while the other avenin peptide QQPFVQQQQPFVQQ did not 
(Real et al., 2012). Furthermore, the single peptide QQPFVQQ did not 
give a response to mAb A1 in a competitive ELISA assay, which is similar 
to the mAb G12 ELISA assay (Moron et al., 2008). It also worth to note 
that QQPFVQQQQQPFVQ and QQPFVQQQQPFVQ are suspected to be 
cleaved by chymotrypsin after Phe residues in human digestion. This 
would result in short peptides, mainly under 9 amino acids long, which 
would not stimulate T-cells, as T-cells require 9 amino acids for acti-
vation (Germain, 1994). Additionally, an interesting cultivar Salo was 
included in this study. The G12 ELISA response was > 40 mg/kg, making 
this cultivar not gluten-free. However, this cultivar was successfully 
used in a previous clinical study (Kemppainen et al., 2008). In the study, 
a daily intake of 100 g for 6 months of both unkilned and regular kilned 
cv. Salo oats was found to be tolerated by 32 adults with CD in remission. 
No changes in duodenal biopsies or levels of endomysial antibodies were 
found. Thus, inconsistency remains between the results of 
antibody-based immunochemical assays, in vitro T-cell activation tests 
and clinical tests for oat avenins. Our results emphasize that conclusions 
on oat cultivars’ immunogenicity cannot be made based on mAb G12 
responses. 
4. Conclusion 
A collection of 26 oat cultivars and landraces was characterised and 
examined for immunochemical activity against mAb R5 and G12. Cul-
tivars and landraces had natural variation in total protein contents and 
avenin contents, protein profiles in SDS-PAGE and chromatograms. 
Neither of the antibodies recognized avenins in immunoblots. According 
to R5 ELISA, the whole collection had no detectable gluten, but the re-
sponses in G12 ELISA ranged from 10 mg/kg to 53 mg/kg. Rather than 
antibody binding being linked to avenin-specific T-cell epitopes, we 
suggest this activity in a sandwich G12 ELISA is due to the binding 
enhancing effect of repetitive regions in some avenin fractions, bringing 
about varying antibody activities both between avenin fractions and 
between oat cultivars. Therefore, G12 ELISA responses most probably 
point to the repetitive regions in avenins, but have not yet been proved 
to indicate celiac immunogenicity of oat cultivars. 
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